Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edwin P Alyea

Showing results (61-70 of 176) with videos related to

Pageof 18
Sort By:
American Journal of Hematology|February 20, 2014
White blood cell recovery after allogeneic hematopoietic cell transplantation predicts clinical outcomeHaesook T Kim, David Frederick, Philippe Armand, et al.
Blood|May 10, 2003
Prior gemtuzumab ozogamicin exposure significantly increases the risk of veno-occlusive disease in patients who undergo myeloablative allogeneic stem cell transplantationMartha Wadleigh, Paul G Richardson, David Zahrieh, et al.
Blood|September 9, 2011
Low telomerase activity in CD4+ regulatory T cells in patients with severe chronic GVHD after hematopoietic stem cell transplantationYutaka Kawano, Haesook T Kim, Ken-Ichi Matsuoka, et al.
Blood|May 13, 2004
Effect of up-front daclizumab when combined with steroids for the treatment of acute graft-versus-host disease: results of a randomized trialStephanie J Lee, David Zahrieh, Edward Agura, et al.
The Journal of Clinical Investigation|April 15, 2010
Altered regulatory T cell homeostasis in patients with CD4+ lymphopenia following allogeneic hematopoietic stem cell transplantationKen-ichi Matsuoka, Haesook T Kim, Sean McDonough, et al.
Cancer Research|January 28, 2010
Efficacious immune therapy in chronic myelogenous leukemia (CML) recognizes antigens that are expressed on CML progenitor cellsMelinda A Biernacki, Ovidiu Marina, Wandi Zhang, et al.
Blood|October 2, 2004
Comparative outcome of nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation for patients older than 50 years of ageEdwin P Alyea, Haesook T Kim, Vincent Ho, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 8, 2014
Donor chimerism early after reduced-intensity conditioning hematopoietic stem cell transplantation predicts relapse and survivalJohn Koreth, Haesook T Kim, Sarah Nikiforow, et al.
Blood|November 25, 2010
Recovery of B-cell homeostasis after rituximab in chronic graft-versus-host diseaseStefanie Sarantopoulos, Kristen E Stevenson, Haesook T Kim, et al.
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology|August 22, 2017
Oral health status and risk of bacteremia following allogeneic hematopoietic cell transplantationAhmed S Sultan, Yvette Zimering, Gloria Petruzziello, et al.
Pageof 18

Showing results (61-70 of 176) with videos related to

Sort By:
Pageof 18
American Journal of Hematology|February 20, 2014
White blood cell recovery after allogeneic hematopoietic cell transplantation predicts clinical outcomeHaesook T Kim, David Frederick, Philippe Armand, et al.
Blood|May 10, 2003
Prior gemtuzumab ozogamicin exposure significantly increases the risk of veno-occlusive disease in patients who undergo myeloablative allogeneic stem cell transplantationMartha Wadleigh, Paul G Richardson, David Zahrieh, et al.
Blood|September 9, 2011
Low telomerase activity in CD4+ regulatory T cells in patients with severe chronic GVHD after hematopoietic stem cell transplantationYutaka Kawano, Haesook T Kim, Ken-Ichi Matsuoka, et al.
Blood|May 13, 2004
Effect of up-front daclizumab when combined with steroids for the treatment of acute graft-versus-host disease: results of a randomized trialStephanie J Lee, David Zahrieh, Edward Agura, et al.
The Journal of Clinical Investigation|April 15, 2010
Altered regulatory T cell homeostasis in patients with CD4+ lymphopenia following allogeneic hematopoietic stem cell transplantationKen-ichi Matsuoka, Haesook T Kim, Sean McDonough, et al.
Cancer Research|January 28, 2010
Efficacious immune therapy in chronic myelogenous leukemia (CML) recognizes antigens that are expressed on CML progenitor cellsMelinda A Biernacki, Ovidiu Marina, Wandi Zhang, et al.
Blood|October 2, 2004
Comparative outcome of nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation for patients older than 50 years of ageEdwin P Alyea, Haesook T Kim, Vincent Ho, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 8, 2014
Donor chimerism early after reduced-intensity conditioning hematopoietic stem cell transplantation predicts relapse and survivalJohn Koreth, Haesook T Kim, Sarah Nikiforow, et al.
Blood|November 25, 2010
Recovery of B-cell homeostasis after rituximab in chronic graft-versus-host diseaseStefanie Sarantopoulos, Kristen E Stevenson, Haesook T Kim, et al.
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology|August 22, 2017
Oral health status and risk of bacteremia following allogeneic hematopoietic cell transplantationAhmed S Sultan, Yvette Zimering, Gloria Petruzziello, et al.
Pageof 18